Vendure genetics correction paid 800,000 not 1 million
281,690 Shares at a deemed price of $0.71 per Share to Vendure in accordance with the Supply Agreement.On December 16, 2019, the Issuer entered into an amendment (the Amendment) to the Supply Agreement, whereby the parties agreed to issue Vendure an additional 800,000 Shares at a deemed price of $0.25 per Share for an aggregate deemed value of $200,000, as well asthe number of Shares that is equal to $150,000 (for clarity, an aggregate of $600,000) as determined at the time of each issuance based on the price of the Shares on the following dates:Total aggregate consideration in Canadian dollars: $800,000 (deemed). All there in black and white. https://webfiles.thecse.com/AGRA_Form_9_-_Vendure_-_Dec_18_2019.pdf?ClR7kCEvEj6uh9iG9Gz4fMiWzo21mgfK